Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-01-15, Stock:ABBV, The news for the past five days is as follows:
2020-01-08: NEWS1: AbbVie to separate Botox in new aesthetics unit; Brent Saunders won't have role.NEWS2: AbbVie Announces Leadership Team and Creation of New Business, Allergan Aesthetics, Upon Completion of Acquisition.
2020-01-09: NEWS1: The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, DBV Announces Positive Peanut Allergy Study Findings, Applied Genetic Soars On Trial Results.
2020-01-10: NEWS1: 7 Healthcare Stocks to Buy or Sell As Pricing Pressures Mount.
2020-01-13: NEWS1: AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know.NEWS2: Chinook Therapeutics' Seattle office just got a new project.NEWS3: Easy Investing Secrets to an Early Retirement - January 13, 2020.NEWS4: AbbVie to Host Fourth-Quarter and Full-Year 2019 Earnings Conference Call.
2020-01-14: NEWS1: The Extreme Risks of Trading Your Own Retirement Assets - January 14, 2020.NEWS2: AbbVie Inc. -- Moody's announces completion of a periodic review of ratings of AbbVie Inc..NEWS3: New Head-to-Head Phase 3 Data Show SKYRIZI™ (risankizumab) Superior to Cosentyx® (secukinumab) Across Primary and All Ranked Secondary Endpoints in Adults with Moderate to Severe Plaque Psoriasis at 52 Weeks.NEWS4: AbbVie's MAVIRET® now listed on the Newfoundland and Labrador formulary.

Answer: Rise